Your browser doesn't support javascript.
loading
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).
Henao-Restrepo, Ana Maria; Camacho, Anton; Longini, Ira M; Watson, Conall H; Edmunds, W John; Egger, Matthias; Carroll, Miles W; Dean, Natalie E; Diatta, Ibrahima; Doumbia, Moussa; Draguez, Bertrand; Duraffour, Sophie; Enwere, Godwin; Grais, Rebecca; Gunther, Stephan; Gsell, Pierre-Stéphane; Hossmann, Stefanie; Watle, Sara Viksmoen; Kondé, Mandy Kader; Kéïta, Sakoba; Kone, Souleymane; Kuisma, Eewa; Levine, Myron M; Mandal, Sema; Mauget, Thomas; Norheim, Gunnstein; Riveros, Ximena; Soumah, Aboubacar; Trelle, Sven; Vicari, Andrea S; Røttingen, John-Arne; Kieny, Marie-Paule.
Afiliación
  • Henao-Restrepo AM; WHO, Geneva, Switzerland. Electronic address: henaorestrepoa@who.int.
  • Camacho A; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
  • Longini IM; Department of Biostatistics, University of Florida, Gainesville, FL, USA.
  • Watson CH; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
  • Edmunds WJ; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
  • Egger M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
  • Carroll MW; Public Health England, London, UK.
  • Dean NE; Department of Biostatistics, University of Florida, Gainesville, FL, USA.
  • Diatta I; Clinical Trials Unit Bern, University of Bern, Bern, Switzerland.
  • Doumbia M; WHO, Geneva, Switzerland; Centre National d'Appui à la Lutte contre la Maladie, Bamako, Mali.
  • Draguez B; Médecins Sans Frontières, Brussels, Belgium.
  • Duraffour S; Bernard Nocht Institute for Tropical Medicine, University of Hamburg, Hamburg, Germany.
  • Enwere G; WHO, Geneva, Switzerland.
  • Grais R; Epicentre, Paris, France.
  • Gunther S; Bernard Nocht Institute for Tropical Medicine, University of Hamburg, Hamburg, Germany.
  • Gsell PS; WHO, Geneva, Switzerland.
  • Hossmann S; Clinical Trials Unit Bern, University of Bern, Bern, Switzerland.
  • Watle SV; Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway.
  • Kondé MK; Center Of Excellence For Training, Research On Malaria & Priority Diseases In Guinea, Conakry, Guinea.
  • Kéïta S; Ebola Response, Ministry of Health, Conakry, Guinea.
  • Kone S; WHO, Geneva, Switzerland.
  • Kuisma E; Bernard Nocht Institute for Tropical Medicine, University of Hamburg, Hamburg, Germany.
  • Levine MM; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Mandal S; Public Health England, London, UK.
  • Mauget T; WHO, Geneva, Switzerland.
  • Norheim G; Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway.
  • Riveros X; WHO, Geneva, Switzerland.
  • Soumah A; Epicentre, Paris, France.
  • Trelle S; Clinical Trials Unit Bern, University of Bern, Bern, Switzerland.
  • Vicari AS; WHO, Geneva, Switzerland.
  • Røttingen JA; Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway; Department of Health and Society, University of Oslo, Norway; Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, USA; Coalition for Epidemic Preparedness Innovati
  • Kieny MP; WHO, Geneva, Switzerland.
Lancet ; 389(10068): 505-518, 2017 02 04.
Article en En | MEDLINE | ID: mdl-28017403
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Vacunas contra el Virus del Ébola Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: Lancet Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Vacunas contra el Virus del Ébola Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: Lancet Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido